In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding

Efstratios Koutroumpakis; Anita Deswal

doi:10.7326/J23-0016

In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding

Efstratios Koutroumpakis, Anita Deswal

Cardiology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

SOURCE CITATION: Khairani CD, Bejjani A, Piazza G, et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol. 2023;81:16-30. 36328154.

Original language	English (US)
Pages (from-to)	JC43
Journal	Annals of internal medicine
Volume	176
Issue number	4
DOIs	https://doi.org/10.7326/J23-0016
State	Published - Apr 2023

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/J23-0016

Cite this

@article{61ca606714514a7a9ccbd99c795f784a,

title = "In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding",

abstract = "SOURCE CITATION: Khairani CD, Bejjani A, Piazza G, et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol. 2023;81:16-30. 36328154.",

author = "Efstratios Koutroumpakis and Anita Deswal",

year = "2023",

month = apr,

doi = "10.7326/J23-0016",

language = "English (US)",

volume = "176",

pages = "JC43",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "4",

}

TY - JOUR

T1 - In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding

AU - Koutroumpakis, Efstratios

AU - Deswal, Anita

PY - 2023/4

Y1 - 2023/4

N2 - SOURCE CITATION: Khairani CD, Bejjani A, Piazza G, et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol. 2023;81:16-30. 36328154.

AB - SOURCE CITATION: Khairani CD, Bejjani A, Piazza G, et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol. 2023;81:16-30. 36328154.

UR - http://www.scopus.com/inward/record.url?scp=85152631790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85152631790&partnerID=8YFLogxK

U2 - 10.7326/J23-0016

DO - 10.7326/J23-0016

M3 - Comment/debate

C2 - 37011391

AN - SCOPUS:85152631790

SN - 0003-4819

VL - 176

SP - JC43

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 4

ER -

In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this